XML 52 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Share-Based Compensation (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2014
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding | A summary of the stock option activity under the Company’s plans for the three months ended September 30, 2014 is as follows:
|  |  |  |  | Weighted |
|  | Number |  |  | average |
|  | of |  |  | exercise |
|  | shares |  |  | price |
Options outstanding at June 30, 2014 |  |  | 14,238,603 |  |  | $ | 23.30 |
Options granted |  |  | 1,000 |  |  |  | 37.17 |
Less: |  |  |  |  |  |  |  |
Options exercised |  |  | 705,944 |  |  |  | 21.39 |
Options canceled or expired |  |  | 83,785 |  |  |  | 24.41 |
Options outstanding at September 30, 2014 |  |  | 13,449,874 |  |  | $ | 23.39 |
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Restricted Stock Units Outstanding | A summary of the RSU activity under the Company’s plans for the three months ended September 30, 2014 is as follows:
|  | Number |  |  | Weighted |
|  | of |  |  | average grant |
|  | shares |  |  | date fair value |
RSUs outstanding at June 30, 2014 |  |  | — |  |  | $ | — |
RSUs granted |  |  | 1,085,733 |  |  |  | 38.12 |
Less: |  |  |  |  |  |  |  |
RSUs vested |  |  | — |  |  |  | — |
RSUs canceled |  |  | 3,200 |  |  |  | 38.12 |
RSUs outstanding at September 30, 2014 |  |  | 1,082,533 |  |  | $ | 38.12 |
Schedule of Share-Based Compensation Recognized in Consolidated Statements of Income and Comprehensive Income | Share-based compensation expense recognized and included in the condensed consolidated statements of income and comprehensive income was allocated as follows:
|  | Three months ended |
|  | September 30, |
(In thousands) |  | 2014 |  |  | 2013 |
Cost of molecular diagnostic testing |  | $ | 198 |  |  | $ | 223 |
Cost of pharmaceutical and clinical services |  |  | 160 |  |  |  | 62 |
Research and development expense |  |  | 764 |  |  |  | 782 |
Selling, general, and administrative expense |  |  | 5,758 |  |  |  | 5,868 |
Total share-based compensation expense |  | $ | 6,880 |  |  | $ | 6,935 |

X
- Definition Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration